About 30M Genomics Private Limited
Data last updated:
30M Genomics Private Limited is a private limited company based in West Godavari District, Andhra Pradesh, India, recognised as a startup by DPIIT. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 18 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U85300AP2019PTC112451.
The company has an authorised share capital of ₹16 Lakh and a paid-up capital of ₹1.24 Lakh. It is led by directors Benet Bosco Dhas and Sasikanta Naga Pavani Pavuluri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Pavuluri Lakshmana Rao Near Church Pavulavarigudem Dwarakatirumala, West Godavari District, Andhra Pradesh, India – 534426.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.68 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹21.64 Lakh (net margin -122.4%) and EBITDA of -₹15.39 Lakh (EBITDA margin -87%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years.
The company is associated with 1 brand: 30M Genomics.
For more details, the company can be reached via its website 30mgenomics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC/O Pavuluri Lakshmana Rao Near Church Pavulavarigudem Dwarakatirumala, West Godavari District, Andhra Pradesh, India – 534426
- IndustryNon-Profit Organizations, Social Work
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with 30M Genomics Private Limited
30M Genomics operates one associated brand: 30M Genomics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Personalized platforms for anticoagulant dosing and sepsis diagnostics are developed. | 30mgenomics.com |
Competitors & Alternatives of 30M Genomics Private Limited
Brands and companies operating in the same space as 30M Genomics Private Limited include Juno Therapeutics, Poseida Therapeutics, Denali Therapeutics and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Juno Therapeutics | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | Seattle, United States | 2013 |
 Poseida Therapeutics | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | San Diego, United States | 2015 |
 Denali Therapeutics | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | San Francisco, United States | 2015 |
 Unilabs | Diagnostic services are provided through laboratories and radiology units. | Geneva, Switzerland | 2000 |
 Unity Biotechnology | Therapeutics for aging diseases are developed by targeting senescent cells. | San Francisco, United States | 2016 |
 Voyager Therapeutics | Gene Therapy to treat CNS diseases such as Parkinson’s disease, ALS. | Cambridge, United States | 2014 |
 Intellia Therapeutics | Therapeutics using CRISPR/Cas9 are developed for various diseases. | Cambridge, United States | 2014 |
 Celsius Therapeutics | Single-cell RNA and genomic analysis for precision therapeutics are provided. | Cambridge, United States | 2018 |
 Castle Biosciences | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | Pittsburgh, United States | 2008 |
Business Activity of 30M Genomics Private Limited
The main business activity of 30M Genomics is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of 30M Genomics Private Limited
30M Genomics Private Limited is audited by NSVR & ASSOCIATES LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NSVR & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of 30M Genomics Private Limited
30M Genomics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Benet Bosco Dhas Also directs: Smartqr Genomics Private Limited, Insyra Private Limited | Director | 18 Jul 2019 | 7 Years 2 Months | Current |
| Sasikanta Naga Pavani Pavuluri Also directs: Insyra Private Limited | Director | 18 Jul 2019 | 7 Years 2 Months | Current |
Financials of 30M Genomics Private Limited FY 2025 filings available
30M Genomics Private Limited reported revenue of ₹17.68 Lakh (down 38% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of 30M Genomics Private Limited
Revenue fell 38% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 64%. EBITDA fell 481% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of 30M Genomics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹15.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹21.64 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of 30M Genomics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -87% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -122.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of 30M Genomics are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of 30M Genomics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of 30M Genomics Private Limited
30M Genomics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at 30M Genomics Private Limited
Employment history and EPFO contributions of people linked to 30M Genomics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of 30M Genomics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for 30M Genomics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by 30M Genomics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of 30M Genomics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of 30M Genomics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on 30M Genomics Private Limited
Frequently Asked Questions about 30M Genomics Private Limited
30M Genomics is an active private limited company based in West Godavari District, Andhra Pradesh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 18 July 2019 (7+ years old) and is registered under CIN U85300AP2019PTC112451.
30M Genomics reported revenue of ₹17.68 Lakh for FY 2024 (down 38% YoY).
30M Genomics has 2 current directors:
- Benet Bosco Dhas - Director
- Sasikanta Naga Pavani Pavuluri - Director
30M Genomics reported a net loss of ₹21.64 Lakh (net margin -122.4%) and EBITDA of -₹15.39 Lakh (EBITDA margin -87%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of 30M Genomics is 64% over three years. In the latest year (FY 2024) revenue fell 38%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of 30M Genomics is U85300AP2019PTC112451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
30M Genomics was incorporated on 18 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
Yes, 30M Genomics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
30M Genomics can be reached through the website 30mgenomics.com. Its registered office is in West Godavari District, Andhra Pradesh, India.